{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T09:21:13Z","timestamp":1782984073842,"version":"3.54.5"},"reference-count":66,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","neurologic.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ncl.2017.08.015","type":"journal-article","created":{"date-parts":[[2017,11,17]],"date-time":"2017-11-17T07:46:52Z","timestamp":1510904812000},"page":"197-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Advanced Symptom Management in Multiple Sclerosis"],"prefix":"10.1016","volume":"36","author":[{"given":"Elizabeth","family":"Crabtree-Hartman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2017.08.015_bib1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1177\/1352458507084264","article-title":"Natural history of secondary progressive multiple sclerosis","volume":"14","author":"Tremlett","year":"2008","journal-title":"Mult Scler"},{"key":"10.1016\/j.ncl.2017.08.015_bib2","first-page":"1148","article-title":"The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset","volume":"262","author":"Tedeholm","year":"2015","journal-title":"J\u00a0Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2017.08.015_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/ana.24747","article-title":"Long-term evolution of multiple sclerosis disability in the treatment era","volume":"80","author":"Cree","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2017.08.015_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1517\/14656566.2012.647767","article-title":"Management options in multiple sclerosis-associated fatigue","volume":"13","author":"Amato","year":"2012","journal-title":"Expert Opin Pharmacother"},{"issue":"11","key":"10.1016\/j.ncl.2017.08.015_bib5","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1001\/jamaneurol.2015.2332","article-title":"Association between glutamate blockade and fatigue in patients with multiple sclerosis","volume":"72","author":"Nourbakhsh","year":"2015","journal-title":"JAMA Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2017.08.015_bib6","first-page":"1417","article-title":"Influence of yoga and aerobics exercise on fatigue, pain and psychosocial status in patients with multiple sclerosis: a randomized trial","volume":"56","author":"Hasanpour Dehkordi","year":"2016","journal-title":"J\u00a0Sports Med Phys Fitness"},{"issue":"4","key":"10.1016\/j.ncl.2017.08.015_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.5539\/gjhs.v7n4p375","article-title":"Effect of acupressure on fatigue in women with multiple sclerosis","volume":"7","author":"Bastani","year":"2015","journal-title":"Glob J Health Sci"},{"issue":"13","key":"10.1016\/j.ncl.2017.08.015_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1212\/WNL.0b013e3181f4d80d","article-title":"MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial","volume":"75","author":"Grossman","year":"2010","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2017.08.015_bib9","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jns.2003.11.005","article-title":"Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomized, double-blind, crossover trial","volume":"218","author":"Tomassini","year":"2004","journal-title":"J\u00a0Neurol Sci"},{"issue":"3","key":"10.1016\/j.ncl.2017.08.015_bib10","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1179\/1476830515Y.0000000002","article-title":"Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: a double blind randomized clinical trial","volume":"19","author":"Sanoobar","year":"2016","journal-title":"Nutr Neurosci"},{"issue":"6","key":"10.1016\/j.ncl.2017.08.015_bib11","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/1352458514554053","article-title":"Effect of alfacalcidol on multiple sclerosis-related fatigue: a randomized, double-blind placebo-controlled study","volume":"21","author":"Achiron","year":"2015","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.ncl.2017.08.015_bib12","first-page":"13","article-title":"Effect of vitamin A supplementation on fatigue and depression in multiple sclerosis patients: a double-blind placebo-controlled clinical trial","volume":"15","author":"Bitarafan","year":"2016","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"12","key":"10.1016\/j.ncl.2017.08.015_bib13","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1177\/1352458511412062","article-title":"American ginseng does not improve fatigue in multiple sclerosis: a single center randomized double-blind placebo-controlled crossover pilot study","volume":"17","author":"Kim","year":"2011","journal-title":"Mult Scler"},{"issue":"7","key":"10.1016\/j.ncl.2017.08.015_bib14","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/00207454.2013.764499","article-title":"Ginseng in the treatment of fatigue in multiple sclerosis: a randomized, placebo-controlled, double-blind pilot study","volume":"123","author":"Etemadifar","year":"2013","journal-title":"Int J Neurosci"},{"issue":"6","key":"10.1016\/j.ncl.2017.08.015_bib15","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1191\/135245801701567050","article-title":"Fatigue in progressive multiple sclerosis: results of a randomized, double-blind, placebo-controlled, crossover trial of oral 4-aminopyridine","volume":"7","author":"Rossini","year":"2001","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.ncl.2017.08.015_bib16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.22006","article-title":"Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis","volume":"68","author":"Cree","year":"2010","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2017.08.015_bib17","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/JCP.0000000000000373","article-title":"Low dose naltrexone for treatment of multiple sclerosis: a retrospective chart review of safety and tolerability","volume":"35","author":"Turel","year":"2015","journal-title":"J\u00a0Clin Psychopharmacol"},{"issue":"9","key":"10.1016\/j.ncl.2017.08.015_bib18","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1179\/1743132812Y.0000000081","article-title":"Comparison of the effect of aspirin and amantadine for the treatment of fatigue in multiple sclerosis: a randomized, blinded, crossover study","volume":"34","author":"Shaygannejad","year":"2012","journal-title":"Neurol Res"},{"issue":"7","key":"10.1016\/j.ncl.2017.08.015_bib19","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1212\/01.WNL.0000158272.27070.6A","article-title":"Modafinil for fatigue in MS: a randomized placebo-controlled double-blind study","volume":"64","author":"Stankoff","year":"2005","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2017.08.015_bib20","first-page":"489","article-title":"Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study","volume":"260","author":"Morrow","year":"2013","journal-title":"J\u00a0Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2017.08.015_bib21","first-page":"1418","article-title":"Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial","volume":"263","author":"Schippling","year":"2016","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2017.08.015_bib22","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1212\/WNL.41.8.1193","article-title":"Cause of death in patients attending multiple sclerosis clinics","volume":"41","author":"Sadovnick","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2017.08.015_bib23","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/jnnp.55.7.542","article-title":"Suicide and multiple sclerosis: an epidemiologic investigation","volume":"55","author":"Stenager","year":"1992","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.ncl.2017.08.015_bib24","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1212\/WNL.59.5.674","article-title":"An examination of suicidal intent in patients with multiple sclerosis","volume":"59","author":"Feinstein","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2017.08.015_bib25","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/jnnp.2004.054635","article-title":"Depression in multiple sclerosis: a review","volume":"76","author":"Siegert","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2017.08.015_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12883-014-0165-4","article-title":"Mindfulness-based interventions in multiple sclerosis: beneficial effects of Tai Chi on balance, coordination, fatigue and depression","volume":"14","author":"Burschka","year":"2014","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ncl.2017.08.015_bib27","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12883-016-0593-4","article-title":"An intensive social cognitive program (can do treatment) in people with relapsing remitting multiple sclerosis and low disability: a randomized controlled trial protocol","volume":"16","author":"Jongen","year":"2016","journal-title":"BMC Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2017.08.015_bib28","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1249\/MSS.0000000000000834","article-title":"Exercising impacts on fatigue, depression, and paresthesia in female patients with multiple sclerosis","volume":"48","author":"Razazian","year":"2016","journal-title":"Med Sci Sports Exerc"},{"issue":"3","key":"10.1016\/j.ncl.2017.08.015_bib29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.pharep.2015.01.002","article-title":"Zinc sulphate: a reasonable choice for depression management in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial","volume":"67","author":"Salari","year":"2015","journal-title":"Pharmacol Rep"},{"issue":"1","key":"10.1016\/j.ncl.2017.08.015_bib30","doi-asserted-by":"crossref","first-page":"e0147195","DOI":"10.1371\/journal.pone.0147195","article-title":"Omega-3 fatty acids for depression in multiple sclerosis: a randomized pilot study","volume":"11","author":"Shinto","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ncl.2017.08.015_bib31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.genhosppsych.2007.08.002","article-title":"Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis","volume":"30","author":"Ehde","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"issue":"4","key":"10.1016\/j.ncl.2017.08.015_bib32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/WNF.0b013e3182996400","article-title":"Duloxetine is effective in treating depression in multiple sclerosis patients: an open-label multicenter study","volume":"36","author":"Solaro","year":"2013","journal-title":"Clin Neuropharmacol"},{"issue":"10","key":"10.1016\/j.ncl.2017.08.015_bib33","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/jnnp-2017-315585","article-title":"Levels of nitric oxide metabolites in cerebrospinal fluid correlate with cognitive impairment in early stage multiple sclerosis","volume":"88","author":"Okada","year":"2017","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.ncl.2017.08.015_bib34","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1177\/1352458511409612","article-title":"Cognitive dysfunction and multiple sclerosis: developing a rationale for considering the efficacy of exercise training","volume":"17","author":"Motl","year":"2011","journal-title":"Mult Scler"},{"issue":"4","key":"10.1016\/j.ncl.2017.08.015_bib35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/1545968312465194","article-title":"Computer-assisted cognitive rehabilitation of attention deficits for multiple sclerosis: a randomized trial with fMRI correlates","volume":"27","author":"Cerasa","year":"2013","journal-title":"Neurorehabil Neural Repair"},{"issue":"7","key":"10.1016\/j.ncl.2017.08.015_bib36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.clineuro.2010.03.006","article-title":"Influence of sports climbing and yoga on spasticity, cognitive function, mood and fatigue in patients with multiple sclerosis","volume":"112","author":"Velikonja","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"issue":"12","key":"10.1016\/j.ncl.2017.08.015_bib37","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1212\/WNL.0b013e31826aac60","article-title":"Ginkgo biloba does not improve cognitive function in MS: a randomized placebo-controlled trial","volume":"79","author":"Lovera","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2017.08.015_bib38","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000342388.73185.80","article-title":"Memantine induces reversible neurologic impairment in patients with MS","volume":"72","author":"Villoslada","year":"2009","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.ncl.2017.08.015_bib39","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e318218107a","article-title":"Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis","volume":"76","author":"Krupp","year":"2011","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2017.08.015_bib40","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/1352458512463481","article-title":"Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients","volume":"19","author":"M\u00e4urer","year":"2013","journal-title":"Mult Scler"},{"issue":"9","key":"10.1016\/j.ncl.2017.08.015_bib41","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1177\/1352458511404585","article-title":"L-amphetamine improves memory in MS patients with objective memory impairment","volume":"17","author":"Sumowski","year":"2011","journal-title":"Mult Scler"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2017.08.015_bib42","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jns.2008.08.025","article-title":"Single dose of methylphenidate improves cognitive performance in multiple sclerosis patients with impaired attention process","volume":"276","author":"Harel","year":"2009","journal-title":"J\u00a0Neurol Sci"},{"issue":"2","key":"10.1016\/j.ncl.2017.08.015_bib43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/10790268.2008.11760706","article-title":"Neurotoxin treatments for urinary incontinence in subjects with spinal cord injury or multiple sclerosis: a systematic review of effectiveness and adverse effects","volume":"31","author":"MacDonald","year":"2008","journal-title":"J\u00a0Spinal Cord Med"},{"issue":"12","key":"10.1016\/j.ncl.2017.08.015_bib44","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/jnnp.2004.045765","article-title":"Placebo controlled, randomized, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients","volume":"76","author":"Gallien","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ncl.2017.08.015_bib45","doi-asserted-by":"crossref","first-page":"563294","DOI":"10.1155\/2013\/563294","article-title":"Neurostimulation for neurogenic bowel dysfunction","volume":"2013","author":"Wors\u00f8e","year":"2013","journal-title":"Gastroenterol Res Pract"},{"issue":"2","key":"10.1016\/j.ncl.2017.08.015_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002115.pub3","article-title":"Management of faecal incontinence and constipation in adults with central neurological diseases","author":"Coggrave","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.ncl.2017.08.015_bib47","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/10790268.2000.11753536","article-title":"Physiologic basis of digital-rectal stimulation for bowel evacuation in patients with spinal cord injury: identification of an anorectal excitatory reflex","volume":"23","author":"Shafik","year":"2000","journal-title":"J\u00a0Spinal Cord Med"},{"issue":"2","key":"10.1016\/j.ncl.2017.08.015_bib48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/1352458510384899","article-title":"Abdominal massage for the alleviation of constipation symptoms in people with multiple sclerosis: a randomized controlled feasibility study","volume":"17","author":"McClurg","year":"2011","journal-title":"Mult Scler"},{"key":"10.1016\/j.ncl.2017.08.015_bib49","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1177\/1352458508093619","article-title":"The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis","volume":"14","author":"Tepavcevic","year":"2008","journal-title":"Mult Scler"},{"issue":"6","key":"10.1016\/j.ncl.2017.08.015_bib50","first-page":"428","article-title":"Sexual dysfunction in multiple sclerosis: II. Correlation analysis","volume":"5","author":"Zivadinov","year":"1999","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.ncl.2017.08.015_bib51","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/1352458506071210","article-title":"Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis","volume":"13","author":"Nortvedt","year":"2007","journal-title":"Mult Scler"},{"key":"10.1016\/j.ncl.2017.08.015_bib52","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1191\/135248506ms1253oa","article-title":"Multiple sclerosis patients with and without sexual dysfunction: are there any differences?","volume":"12","author":"Demirikiran","year":"2006","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.ncl.2017.08.015_bib53","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/jnnp.59.1.83","article-title":"Sexual function in women with advanced multiple sclerosis","volume":"59","author":"Hulter","year":"1995","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.ncl.2017.08.015_bib54","first-page":"255","article-title":"Sexual dysfunction in relapsing-remitting multiple sclerosis: magnetic resonance imaging, clinical, and psychological correlates","volume":"21","author":"Barak","year":"1996","journal-title":"J\u00a0Psychiatry Neurosci"},{"issue":"1","key":"10.1016\/j.ncl.2017.08.015_bib55","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1191\/1352458503ms881sr","article-title":"Correlation of sexual dysfunction and brain magnetic resonance imaging in multiple sclerosis","volume":"9","author":"Zorzon","year":"2003","journal-title":"Mult Scler"},{"issue":"13","key":"10.1016\/j.ncl.2017.08.015_bib56","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1177\/1352458514531520","article-title":"The effect of pelvic floor muscle training alone or in combination with electrostimulation in the treatment of sexual dysfunction in women with multiple sclerosis","volume":"20","author":"L\u00facio","year":"2014","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.ncl.2017.08.015_bib57","first-page":"1189","article-title":"Efficacy of sildenafil in the treatment of female sexual dysfunction due to multiple sclerosis","volume":"171","author":"Dasgupta","year":"2004","journal-title":"J\u00a0Urol"},{"issue":"1","key":"10.1016\/j.ncl.2017.08.015_bib58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/S0317167100027104","article-title":"Tizanidine versus baclofen in the treatment of spasticity in patients with multiple sclerosis","volume":"15","author":"Bass","year":"1988","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"10.1016\/j.ncl.2017.08.015_bib59","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0003-9993(00)90135-7","article-title":"Gabapentin effect on spasticity in multiple sclerosis: a placebo-controlled, randomized trial","volume":"81","author":"Cutter","year":"2000","journal-title":"Arch Phys Med Rehabil"},{"issue":"10","key":"10.1016\/j.ncl.2017.08.015_bib60","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1503\/cmaj.110837","article-title":"Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial","volume":"184","author":"Corey-Bloom","year":"2012","journal-title":"CMAJ"},{"issue":"9395","key":"10.1016\/j.ncl.2017.08.015_bib61","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(03)14738-1","article-title":"Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial","volume":"362","author":"Zajicek","year":"2003","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ncl.2017.08.015_bib62","first-page":"2520","article-title":"Sativex(\u00ae) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis","volume":"262","author":"Leocani","year":"2015","journal-title":"J\u00a0Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2017.08.015_bib63","first-page":"285","article-title":"Sativex long-term use: an open-label trial in patients with spasticity due to multiple sclerosis","volume":"260","author":"Serpell","year":"2013","journal-title":"J\u00a0Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2017.08.015_bib64","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.mayocp.2015.01.018","article-title":"Neuropathic pain: principles of diagnosis and treatment","volume":"90","author":"Gilron","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.ncl.2017.08.015_bib65","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/pme.12569","article-title":"Nabilone as an adjunctive to gabapentin for multiple sclerosis-induced neuropathic pain: a randomized controlled trial","volume":"16","author":"Turcotte","year":"2015","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.ncl.2017.08.015_bib66","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.msard.2015.01.005","article-title":"High doses of biotin in chronic progressive multiple sclerosis: a pilot study","volume":"4","author":"Sedel","year":"2015","journal-title":"Mult Scler Relat Disord"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861917301020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861917301020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T18:55:25Z","timestamp":1719600925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861917301020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0733861917301020"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2017.08.015","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advanced Symptom Management in Multiple Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2017.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}